Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.

Bassler D, Shinwell ES, Hallman M, Jarreau PH, Plavka R, Carnielli V, Meisner C, Engel C, Koch A, Kreutzer K, van den Anker JN, Schwab M, Halliday HL, Poets CF; Neonatal European Study of Inhaled Steroids Trial Group.

N Engl J Med. 2018 Jan 11;378(2):148-157. doi: 10.1056/NEJMoa1708831.

2.

Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.

Bassler D, Plavka R, Shinwell ES, Hallman M, Jarreau PH, Carnielli V, Van den Anker JN, Meisner C, Engel C, Schwab M, Halliday HL, Poets CF; NEUROSIS Trial Group.

N Engl J Med. 2015 Oct 15;373(16):1497-506. doi: 10.1056/NEJMoa1501917.

3.

Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.

Bassler D.

Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Review.

PMID:
26044104
4.

Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.

Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD.

N Engl J Med. 2005 Jul 7;353(1):23-32.

5.

Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.

Baud O, Trousson C, Biran V, Leroy E, Mohamed D, Alberti C; PREMILOC Trial Group.

JAMA. 2017 Apr 4;317(13):1329-1337. doi: 10.1001/jama.2017.2692.

PMID:
28384828
6.

Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.

Serenius F, Källén K, Blennow M, Ewald U, Fellman V, Holmström G, Lindberg E, Lundqvist P, Maršál K, Norman M, Olhager E, Stigson L, Stjernqvist K, Vollmer B, Strömberg B; EXPRESS Group.

JAMA. 2013 May 1;309(17):1810-20. doi: 10.1001/jama.2013.3786.

PMID:
23632725
7.

Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.

Pierrat V, Marchand-Martin L, Arnaud C, Kaminski M, Resche-Rigon M, Lebeaux C, Bodeau-Livinec F, Morgan AS, Goffinet F, Marret S, Ancel PY; EPIPAGE-2 writing group.

BMJ. 2017 Aug 16;358:j3448. doi: 10.1136/bmj.j3448.

8.

Long-term effects of caffeine therapy for apnea of prematurity.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group.

N Engl J Med. 2007 Nov 8;357(19):1893-902.

9.
10.

Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration.

Askie LM, Darlow BA, Finer N, Schmidt B, Stenson B, Tarnow-Mordi W, Davis PG, Carlo WA, Brocklehurst P, Davies LC, Das A, Rich W, Gantz MG, Roberts RS, Whyte RK, Costantini L, Poets C, Asztalos E, Battin M, Halliday HL, Marlow N, Tin W, King A, Juszczak E, Morley CJ, Doyle LW, Gebski V, Hunter KE, Simes RJ; Neonatal Oxygenation Prospective Meta-analysis (NeOProM) Collaboration.

JAMA. 2018 Jun 5;319(21):2190-2201. doi: 10.1001/jama.2018.5725. Erratum in: JAMA. 2018 Jul 17;320(3):308.

PMID:
29872859
11.

Inhaled budesonide for the prevention of bronchopulmonary dysplasia.

Bassler D.

J Matern Fetal Neonatal Med. 2017 Oct;30(19):2372-2374. doi: 10.1080/14767058.2016.1248937. Epub 2016 Nov 8. Review.

PMID:
27756156
12.

Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.

Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF; Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators.

JAMA. 2003 Mar 5;289(9):1124-9.

PMID:
12622582
13.

Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.

Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE; NO CLD Study Group.

N Engl J Med. 2006 Jul 27;355(4):343-53. Erratum in: N Engl J Med. 2007 Oct 4;357(14):1444-5.

14.

Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.

Vaucher YE, Peralta-Carcelen M, Finer NN, Carlo WA, Gantz MG, Walsh MC, Laptook AR, Yoder BA, Faix RG, Das A, Schibler K, Rich W, Newman NS, Vohr BR, Yolton K, Heyne RJ, Wilson-Costello DE, Evans PW, Goldstein RF, Acarregui MJ, Adams-Chapman I, Pappas A, Hintz SR, Poindexter B, Dusick AM, McGowan EC, Ehrenkranz RA, Bodnar A, Bauer CR, Fuller J, O'Shea TM, Myers GJ, Higgins RD; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network.

N Engl J Med. 2012 Dec 27;367(26):2495-504. doi: 10.1056/NEJMoa1208506.

15.

The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants.

Bassler D, Halliday HL, Plavka R, Hallman M, Shinwell ES, Jarreau PH, Carnielli V, van den Anker J, Schwab M, Poets CF.

Neonatology. 2010;97(1):52-5. doi: 10.1159/000227294. Epub 2009 Jul 7. No abstract available.

PMID:
19590247
16.

Inhaled Glucocorticoids and Pneumonia in Preterm Infants: Post Hoc Results from the NEuroSIS Trial.

Koch A, Kreutzer K, von Oldershausen G, Poets CF, Bassler D; NEuroSIS Trial Group.

Neonatology. 2017;112(2):110-113. doi: 10.1159/000468507. Epub 2017 Apr 29.

PMID:
28456800
17.

Risk of neurodevelopmental impairment for outborn extremely preterm infants in an Australian regional network.

Mahoney K, Bajuk B, Oei J, Lui K, Abdel-Latif ME; NICUS Network.

J Matern Fetal Neonatal Med. 2017 Jan;30(1):96-102. Epub 2016 Jun 1.

PMID:
26957041
18.

Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.

Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Baldassarre J; EUNO Study Group.

Lancet. 2010 Jul 31;376(9738):346-54. doi: 10.1016/S0140-6736(10)60664-2. Epub 2010 Jul 23.

PMID:
20655106
19.

Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.

Zhang ZQ, Zhong Y, Huang XM, Du LZ.

BMC Pulm Med. 2017 Dec 15;17(1):207. doi: 10.1186/s12890-017-0550-z. Review.

20.

Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants.

Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K; New South Wales and Australian Capital Territory Neonatal Intensive Care Units' Data Collection.

Pediatrics. 2014 Jan;133(1):55-62. doi: 10.1542/peds.2013-0372. Epub 2013 Dec 30.

PMID:
24379238

Supplemental Content

Support Center